Follow Us
HIV Treatment and Medical Care

Isentress (Raltegravir, MK-0518)

The Latest

An Overview of Isentress (Raltegravir) Img

An Overview of Isentress (Raltegravir)

Brand Name: Isentress Other Name(s): RAL, raltegravir potassium Drug Class: Integrase Inhibitors

Raltegravir (Isentress) Img

Raltegravir (Isentress)

Table of Contents

What Is Raltegravir? Who Should Take It? What About Drug Resistance? How Is Raltegravir Taken? What Are the Side Effects? How Does It React With Other Drugs? The Bottom Line

What Is Raltegravir?

Raltegravir (Isentress...

Promo Image


Brand name: Isentress

Generic name: raltegravir, or RAL

Class: Integrase inhibitor (integrase strand transfer inhibitor, or INSTI)

Manufacturer: Merck and Co.,, (800) 622-4477

AWP: $1,171.31/month

Standard Dose: One 400 mg film...

Promo Image

FAQs About Isentress (Raltegravir)

Don't see your question? Ask it in our Choosing Your Meds forum or Managing Side Effects of HIV Treatment forum!

Starting Treatment | Switching Treatment | Side Effects | Adherence | Insurance

Starting Treatment

Which HIV meds should I take along ...

Promo Image

Switching Isentress to Once a Day Is Less Effective

Although the integrase inhibitor Isentress (raltegravir) is recommended for people going on treatment for the first time, it's the only first line drug that's taken twice, not once, a day. In an effort to simplify the dosing, a study compared taking ...

Promo Image

The Bottom Line on Isentress: An Interview With David Wohl, M.D. (Part I)

This is Part I of an update on Isentress. For Part II, an explanation of how Isentress works, please click here.

On Oct. 12, the U.S. Food and Drug Administration approved Isentress, the first member of a new class of meds called integrase inhibitor...

Promo Image

How Isentress Works: An Interview With David Wohl, M.D. (Part II)

This is Part II of an update on Isentress. For a general overview, please click here.

Could you briefly describe how Isentress differs from other meds?

Isentress, also called raltegravir [called MK-0518 during its early development], is a drug th...

Promo Image

New Experimental Drug Integrase Inhibitor (MK-0518)

For the last six years, treatment has driven the AIDS agenda. Just this past summer, the Food and Drug Administration (FDA) approved Prezista, a new Protease Inhibitor, as well as Atripla, the first once-daily single tablet regiment for adults with...